Trial PCNSL

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

PCNSL

Full title

Temsirolimus bei PZNSL

Description

Therapy and pharmacokinetic study of temsirolimus in
refractory or relapsed primary CNS lymphoma
(PZNSL)

Therapie- und Pharmakokinetikstudie von Temsirolimus bei
refraktärem oder rezidiviertem primärem ZNS Lymphom
(PZNSL)

EudraCT number

2009-011277-33

NCT number

NCT00942747

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Classification	Code	Description
ICD-10-GM	C85.9	Non-Hodgkin-Lymphom, nicht näher bezeichnet
-		CNS Tumors
-		Bloodcancer (leukemia, lymphoma)

Trial type

Interventional

Blinding type

Open

Phase

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2014-06-30 / Unknown

Therapy line

	Function	Prename	Surname	Organization
	Principal Investigator	MARTIN	DREYLING	Keine Organisationseinheit angegeben
	Responsible contact	Carmen	Carlucci	Keine Organisationseinheit angegeben